Literature DB >> 33351847

Coronavirus genomes carry the signatures of their habitats.

Yulong Wei1, Jordan R Silke1, Parisa Aris1, Xuhua Xia1,2.   

Abstract

pan class="Species">Coronaviruses such as class="Chemical">pan class="Species">SARS-CoV-2 regularly infect host tissues that express antiviral proteins (AVPs) in abundance. Understanding how they evolve to adapt or evade host immune responses is important in the effort to control the spread of infection. Two AVPs that may shape viral genomes are the zinc finger antiviral protein (ZAP) and the apolipoprotein B mRNA editing enzyme-catalytic polypeptide-like 3 (APOBEC3). The former binds to CpG dinucleotides to facilitate the degradation of viral transcripts while the latter frequently deaminates C into U residues which could generate notable viral sequence variations. We tested the hypothesis that both APOBEC3 and ZAP impose selective pressures that shape the genome of an infecting coronavirus. Our investigation considered a comprehensive number of publicly available genomes for seven coronaviruses (SARS-CoV-2, SARS-CoV, and MERS infecting Homo sapiens, Bovine CoV infecting Bos taurus, MHV infecting Mus musculus, HEV infecting Sus scrofa, and CRCoV infecting Canis lupus familiaris). We show that coronaviruses that regularly infect tissues with abundant AVPs have CpG-deficient and U-rich genomes; whereas those that do not infect tissues with abundant AVPs do not share these sequence hallmarks. Among the coronaviruses surveyed herein, CpG is most deficient in SARS-CoV-2 and a temporal analysis showed a marked increase in C to U mutations over four months of SARS-CoV-2 genome evolution. Furthermore, the preferred motifs in which these C to U mutations occur are the same as those subjected to APOBEC3 editing in HIV-1. These results suggest that both ZAP and APOBEC3 shape the SARS-CoV-2 genome: ZAP imposes a strong CpG avoidance, and APOBEC3 constantly edits C to U. Evolutionary pressures exerted by host immune systems onto viral genomes may motivate novel strategies for SARS-CoV-2 vaccine development.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33351847      PMCID: PMC7755226          DOI: 10.1371/journal.pone.0244025

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  108 in total

1.  Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.

Authors:  Qin Yu; Renate König; Satish Pillai; Kristopher Chiles; Mary Kearney; Sarah Palmer; Douglas Richman; John M Coffin; Nathaniel R Landau
Journal:  Nat Struct Mol Biol       Date:  2004-04-18       Impact factor: 15.369

2.  SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.

Authors:  Nina Le Bert; Anthony T Tan; Kamini Kunasegaran; Christine Y L Tham; Morteza Hafezi; Adeline Chia; Melissa Hui Yen Chng; Meiyin Lin; Nicole Tan; Martin Linster; Wan Ni Chia; Mark I-Cheng Chen; Lin-Fa Wang; Eng Eong Ooi; Shirin Kalimuddin; Paul Anantharajah Tambyah; Jenny Guek-Hong Low; Yee-Joo Tan; Antonio Bertoletti
Journal:  Nature       Date:  2020-07-15       Impact factor: 49.962

3.  Biochemical Basis of APOBEC3 Deoxycytidine Deaminase Activity on Diverse DNA Substrates.

Authors:  Madison B Adolph; Robin P Love; Linda Chelico
Journal:  ACS Infect Dis       Date:  2018-02-09       Impact factor: 5.084

4.  Structure of the zinc-finger antiviral protein in complex with RNA reveals a mechanism for selective targeting of CG-rich viral sequences.

Authors:  Jennifer L Meagher; Matthew Takata; Daniel Gonçalves-Carneiro; Sarah C Keane; Antoine Rebendenne; Heley Ong; Victoria K Orr; Margaret R MacDonald; Jeanne A Stuckey; Paul D Bieniasz; Janet L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-12       Impact factor: 11.205

5.  The zinc-finger antiviral protein recruits the RNA processing exosome to degrade the target mRNA.

Authors:  Xuemin Guo; Jing Ma; Jing Sun; Guangxia Gao
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-21       Impact factor: 12.779

6.  APOBEC3 proteins can copackage and comutate HIV-1 genomes.

Authors:  Belete A Desimmie; Ryan C Burdick; Taisuke Izumi; Hibiki Doi; Wei Shao; W Gregory Alvord; Kei Sato; Yoshio Koyanagi; Sara Jones; Eleanor Wilson; Shawn Hill; Frank Maldarelli; Wei-Shau Hu; Vinay K Pathak
Journal:  Nucleic Acids Res       Date:  2016-07-20       Impact factor: 16.971

7.  Bovine Genome Database: new annotation tools for a new reference genome.

Authors:  Md Shamimuzzaman; Justin J Le Tourneau; Deepak R Unni; Colin M Diesh; Deborah A Triant; Amy T Walsh; Aditi Tayal; Gavin C Conant; Darren E Hagen; Christine G Elsik
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

8.  CpG-Recoding in Zika Virus Genome Causes Host-Age-Dependent Attenuation of Infection With Protection Against Lethal Heterologous Challenge in Mice.

Authors:  Ivan Trus; Daniel Udenze; Nathalie Berube; Colette Wheler; Marie-Jocelyne Martel; Volker Gerdts; Uladzimir Karniychuk
Journal:  Front Immunol       Date:  2020-01-24       Impact factor: 7.561

9.  Intra-genome variability in the dinucleotide composition of SARS-CoV-2.

Authors:  Paul Digard; Hui Min Lee; Colin Sharp; Finn Grey; Eleanor Gaunt
Journal:  Virus Evol       Date:  2020-08-13
View more
  13 in total

Review 1.  HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens.

Authors:  Will Fischer; Elena E Giorgi; Srirupa Chakraborty; Kien Nguyen; Tanmoy Bhattacharya; James Theiler; Pablo A Goloboff; Hyejin Yoon; Werner Abfalterer; Brian T Foley; Houriiyah Tegally; James Emmanuel San; Tulio de Oliveira; Sandrasegaram Gnanakaran; Bette Korber
Journal:  Cell Host Microbe       Date:  2021-06-03       Impact factor: 31.316

2.  The Heterogeneous Landscape and Early Evolution of Pathogen-Associated CpG Dinucleotides in SARS-CoV-2.

Authors:  Andrea Di Gioacchino; Petr Šulc; Anastassia V Komarova; Benjamin D Greenbaum; Rémi Monasson; Simona Cocco
Journal:  Mol Biol Evol       Date:  2021-05-19       Impact factor: 16.240

Review 3.  Host-directed editing of the SARS-CoV-2 genome.

Authors:  Tobias Mourier; Mukhtar Sadykov; Michael J Carr; Gabriel Gonzalez; William W Hall; Arnab Pain
Journal:  Biochem Biophys Res Commun       Date:  2020-11-05       Impact factor: 3.575

Review 4.  Domains and Functions of Spike Protein in Sars-Cov-2 in the Context of Vaccine Design.

Authors:  Xuhua Xia
Journal:  Viruses       Date:  2021-01-14       Impact factor: 5.048

5.  The Roles of APOBEC-mediated RNA Editing in SARS-CoV-2 Mutations, Replication and Fitness.

Authors:  Kyumin Kim; Peter Calabrese; Shanshan Wang; Chao Qin; Youliang Rao; Pinghui Feng; Xiaojiang S Chen
Journal:  bioRxiv       Date:  2022-04-07

6.  Striking lineage diversity of severe acute respiratory syndrome coronavirus 2 from non-human sources.

Authors:  Marina Muñoz; Luz Helena Patiño; Nathalia Ballesteros; Sergio Castañeda; Nicolás Luna; Lourdes Delgado; Carlos Hernandez-Pereira; Maryia V Shaban; Shirly Alexandra Muñoz; Alberto Paniz-Mondolfi; Juan David Ramírez
Journal:  One Health       Date:  2021-12-16

7.  The substitution spectra of coronavirus genomes.

Authors:  Diego Forni; Rachele Cagliani; Chiara Pontremoli; Mario Clerici; Manuela Sironi
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 11.622

Review 8.  Cytidine deamination-induced perpetual immunity to SAR-CoV-2 infection is a potential new therapeutic target.

Authors:  Asad Ullah; Neelam Mabood; Muhammad Maqbool; Luqman Khan; Mujib Ullah
Journal:  Int J Med Sci       Date:  2021-10-15       Impact factor: 3.738

9.  Intra-host evolution during SARS-CoV-2 prolonged infection.

Authors:  Carolina M Voloch; Ronaldo da Silva Francisco; Luiz G P de Almeida; Otavio J Brustolini; Cynthia C Cardoso; Alexandra L Gerber; Ana Paula de C Guimarães; Isabela de Carvalho Leitão; Diana Mariani; Victor Akira Ota; Cristiano X Lima; Mauro M Teixeira; Ana Carolina F Dias; Rafael Mello Galliez; Débora Souza Faffe; Luís Cristóvão Pôrto; Renato S Aguiar; Terezinha M P P Castiñeira; Orlando C Ferreira; Amilcar Tanuri; Ana Tereza R de Vasconcelos
Journal:  Virus Evol       Date:  2021-09-29

10.  AID and APOBECs as Multifaceted Intrinsic Virus-Restricting Factors: Emerging Concepts in the Light of COVID-19.

Authors:  Anastasia Meshcheryakova; Peter Pietschmann; Philip Zimmermann; Igor B Rogozin; Diana Mechtcheriakova
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.